840 related articles for article (PubMed ID: 22626821)
1. Normal and pathologic concentrations of uremic toxins.
Duranton F; Cohen G; De Smet R; Rodriguez M; Jankowski J; Vanholder R; Argiles A;
J Am Soc Nephrol; 2012 Jul; 23(7):1258-70. PubMed ID: 22626821
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
Yamamoto S
Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
[TBL] [Abstract][Full Text] [Related]
3. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
[TBL] [Abstract][Full Text] [Related]
4. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.
Vanholder R; Schepers E; Pletinck A; Nagler EV; Glorieux G
J Am Soc Nephrol; 2014 Sep; 25(9):1897-907. PubMed ID: 24812165
[TBL] [Abstract][Full Text] [Related]
5. Protein-bound uremic toxins: new insight from clinical studies.
Liabeuf S; Drüeke TB; Massy ZA
Toxins (Basel); 2011 Jul; 3(7):911-9. PubMed ID: 22069747
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.
Vanholder R; Pletinck A; Schepers E; Glorieux G
Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29316724
[TBL] [Abstract][Full Text] [Related]
7. The specific impact of uremic toxins upon cognitive domains: a review.
Franco ÁO; Starosta RT; Roriz-Cruz M
J Bras Nefrol; 2019; 41(1):103-111. PubMed ID: 30095142
[TBL] [Abstract][Full Text] [Related]
8. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
[TBL] [Abstract][Full Text] [Related]
9. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
Mutsaers HA; Engelke UF; Wilmer MJ; Wetzels JF; Wevers RA; van den Heuvel LP; Hoenderop JG; Masereeuw R
PLoS One; 2013; 8(8):e71199. PubMed ID: 23936492
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
12. Effect of uremic toxin-indoxyl sulfate on the skeletal system.
Liu WC; Wu CC; Lim PS; Chien SW; Hou YC; Zheng CM; Shyu JF; Lin YF; Lu KC
Clin Chim Acta; 2018 Sep; 484():197-206. PubMed ID: 29864403
[TBL] [Abstract][Full Text] [Related]
13. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
[TBL] [Abstract][Full Text] [Related]
14. Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins.
Eloot S; Schepers E; Barreto DV; Barreto FC; Liabeuf S; Van Biesen W; Verbeke F; Glorieux G; Choukroun G; Massy Z; Vanholder R
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1266-73. PubMed ID: 21617084
[TBL] [Abstract][Full Text] [Related]
15. In vitro Removal of Protein-Bound Retention Solutes by Extracorporeal Blood Purification Procedures.
Schildboeck C; Harm S; Hartmann J
Blood Purif; 2024; 53(4):231-242. PubMed ID: 38262384
[TBL] [Abstract][Full Text] [Related]
16. Carbon Adsorbents With Dual Porosity for Efficient Removal of Uremic Toxins and Cytokines from Human Plasma.
Pavlenko D; Giasafaki D; Charalambopoulou G; van Geffen E; Gerritsen KGF; Steriotis T; Stamatialis D
Sci Rep; 2017 Nov; 7(1):14914. PubMed ID: 29097715
[TBL] [Abstract][Full Text] [Related]
17. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.
Eloot S; Van Biesen W; Roels S; Delrue W; Schepers E; Dhondt A; Vanholder R; Glorieux G
PLoS One; 2017; 12(10):e0186010. PubMed ID: 29016645
[TBL] [Abstract][Full Text] [Related]
19. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
